文献
J-GLOBAL ID:201702244808368108
整理番号:17A1381815
連続対中断療法を受けたリバロキサバン治療患者における静脈血栓塞栓症再発のリスク:静脈血栓塞栓症患者における解析【Powered by NICT】
Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE
著者 (12件):
Khorana Alok A.
(Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio)
,
Berger Jeffrey S.
(New York University School of Medicine, New York, New York)
,
Wells Philip S.
(The Ottawa Hospital, Ottawa, Ontario, Canada)
,
Seheult Roger
(Loma Linda University School of Medicine, Loma Linda, California)
,
Ashton Veronica
(Janssen Scientific Affairs, LLC, Raritan, New Jersey)
,
Laliberte Francois
(Groupe d’analyse, Ltee, Montreal, Quebec, Canada)
,
Crivera Concetta
(Janssen Scientific Affairs, LLC, Raritan, New Jersey)
,
Lejeune Dominique
(Groupe d’analyse, Ltee, Montreal, Quebec, Canada)
,
Schein Jeff
(Janssen Scientific Affairs, LLC, Raritan, New Jersey)
,
Wildgoose Peter
(Janssen Scientific Affairs, LLC, Raritan, New Jersey)
,
Lefebvre Patrick
(Groupe d’analyse, Ltee, Montreal, Quebec, Canada)
,
Kaatz Scott
(Henry Ford Hospital, Detroit, Michigan)
資料名:
Clinical Therapeutics
(Clinical Therapeutics)
巻:
39
号:
7
ページ:
1396-1408
発行年:
2017年
JST資料番号:
A1157A
ISSN:
0149-2918
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)